ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CD25 (IL2R alpha) Antibody Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-18D12396
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global CD25 IL2R alpha Antibody Market Research Report 2022
BUY CHAPTERS

Global CD25 (IL2R alpha) Antibody Market Research Report 2024

Code: QYRE-Auto-18D12396
Report
April 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lifespan Biosciences Inc.
Bio-Techne
Abeomics
Abcam
Boster Biological Technology
MyBioSource
Abbexa
Merck
Arigo Biolaboratories Corp
Leinco Technologies
Diagnostic BioSystems
Creative Diagnostics
BioLegend
Sino Biological Inc

CD25 (IL2R alpha) Antibody Market Size

The global CD25 (IL2R alpha) Antibody market was valued at US$ 394.6 million in 2023 and is anticipated to reach US$ 894.4 million by 2030, witnessing a CAGR of 12.4% during the forecast period 2024-2030.

CD25 (IL2R alpha) Antibody Market

CD25 (IL2R alpha) Antibody Market

CD25 (IL2R alpha) Antibody is an antibody directed against the CD25 protein (interleukin-2 receptor alpha chain) in the human immune system.
CD25 is the α subunit of the IL-2 receptor and is widely expressed on the surface of regulatory T cells (Tregs) and other activated immune cells. The binding of this antibody can interfere with IL-2 signaling and affect cell proliferation, differentiation and immune response, especially the negative regulation of immune response. Therefore, CD25 antibody is used as a potential tool for immunomodulatory therapy aimed at modulating the activity of the immune system for the treatment of autoimmune diseases, organ transplant rejection and other diseases, as well as possible applications in the treatment of certain tumors. This makes CD25 antibodies one of the areas of great interest in immunotherapy research.
This report aims to provide a comprehensive presentation of the global market for CD25 (IL2R alpha) Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD25 (IL2R alpha) Antibody.

Report Scope

The CD25 (IL2R alpha) Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CD25 (IL2R alpha) Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD25 (IL2R alpha) Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CD25 (IL2R alpha) Antibody Market Report

Report Metric Details
Report Name CD25 (IL2R alpha) Antibody Market
Accounted market size in 2023 US$ 394.6 million
Forecasted market size in 2030 US$ 894.4 million
CAGR 12.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Monoclonal Antibody
  • Polyclonal Antibody
Segment by Application
  • Flow Cytometry
  • ELISA
  • Western Blot
  • Immunoprecipitation
  • Immunofluorescence
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sino Biological, Inc., LifeSpan BioSciences, Inc, Bio-Techne, Abeomics Inc., Abcam, Boster Biological Technology, MyBiosource, Inc., BioLegend, Abbexa, Merck, Arigo Biolaboratories Corp., Leinco Technologies, Diagnostic BioSystems, Creative Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of CD25 (IL2R alpha) Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of CD25 (IL2R alpha) Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is CD25 (IL2R alpha) Antibody Market growing?

Ans: The CD25 (IL2R alpha) Antibody Market witnessing a CAGR of 12.4% during the forecast period 2024-2030.

What is the CD25 (IL2R alpha) Antibody Market size in 2030?

Ans: The CD25 (IL2R alpha) Antibody Market size in 2030 will be US$ 894.4 million.

Who are the main players in the CD25 (IL2R alpha) Antibody Market report?

Ans: The main players in the CD25 (IL2R alpha) Antibody Market are Sino Biological, Inc., LifeSpan BioSciences, Inc, Bio-Techne, Abeomics Inc., Abcam, Boster Biological Technology, MyBiosource, Inc., BioLegend, Abbexa, Merck, Arigo Biolaboratories Corp., Leinco Technologies, Diagnostic BioSystems, Creative Diagnostics

What are the Application segmentation covered in the CD25 (IL2R alpha) Antibody Market report?

Ans: The Applications covered in the CD25 (IL2R alpha) Antibody Market report are Flow Cytometry, ELISA, Western Blot, Immunoprecipitation, Immunofluorescence, Others

What are the Type segmentation covered in the CD25 (IL2R alpha) Antibody Market report?

Ans: The Types covered in the CD25 (IL2R alpha) Antibody Market report are Monoclonal Antibody, Polyclonal Antibody

1 CD25 (IL2R alpha) Antibody Market Overview
1.1 Product Overview and Scope of CD25 (IL2R alpha) Antibody
1.2 CD25 (IL2R alpha) Antibody Segment by Type
1.2.1 Global CD25 (IL2R alpha) Antibody Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 CD25 (IL2R alpha) Antibody Segment by Application
1.3.1 Global CD25 (IL2R alpha) Antibody Market Value by Application: (2024-2030)
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Others
1.4 Global CD25 (IL2R alpha) Antibody Market Size Estimates and Forecasts
1.4.1 Global CD25 (IL2R alpha) Antibody Revenue 2019-2030
1.4.2 Global CD25 (IL2R alpha) Antibody Sales 2019-2030
1.4.3 Global CD25 (IL2R alpha) Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 CD25 (IL2R alpha) Antibody Market Competition by Manufacturers
2.1 Global CD25 (IL2R alpha) Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global CD25 (IL2R alpha) Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global CD25 (IL2R alpha) Antibody Average Price by Manufacturers (2019-2024)
2.4 Global CD25 (IL2R alpha) Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CD25 (IL2R alpha) Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD25 (IL2R alpha) Antibody, Product Type & Application
2.7 CD25 (IL2R alpha) Antibody Market Competitive Situation and Trends
2.7.1 CD25 (IL2R alpha) Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CD25 (IL2R alpha) Antibody Players Market Share by Revenue
2.7.3 Global CD25 (IL2R alpha) Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CD25 (IL2R alpha) Antibody Retrospective Market Scenario by Region
3.1 Global CD25 (IL2R alpha) Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global CD25 (IL2R alpha) Antibody Global CD25 (IL2R alpha) Antibody Sales by Region: 2019-2030
3.2.1 Global CD25 (IL2R alpha) Antibody Sales by Region: 2019-2024
3.2.2 Global CD25 (IL2R alpha) Antibody Sales by Region: 2025-2030
3.3 Global CD25 (IL2R alpha) Antibody Global CD25 (IL2R alpha) Antibody Revenue by Region: 2019-2030
3.3.1 Global CD25 (IL2R alpha) Antibody Revenue by Region: 2019-2024
3.3.2 Global CD25 (IL2R alpha) Antibody Revenue by Region: 2025-2030
3.4 North America CD25 (IL2R alpha) Antibody Market Facts & Figures by Country
3.4.1 North America CD25 (IL2R alpha) Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America CD25 (IL2R alpha) Antibody Sales by Country (2019-2030)
3.4.3 North America CD25 (IL2R alpha) Antibody Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD25 (IL2R alpha) Antibody Market Facts & Figures by Country
3.5.1 Europe CD25 (IL2R alpha) Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe CD25 (IL2R alpha) Antibody Sales by Country (2019-2030)
3.5.3 Europe CD25 (IL2R alpha) Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD25 (IL2R alpha) Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific CD25 (IL2R alpha) Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific CD25 (IL2R alpha) Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific CD25 (IL2R alpha) Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD25 (IL2R alpha) Antibody Market Facts & Figures by Country
3.7.1 Latin America CD25 (IL2R alpha) Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America CD25 (IL2R alpha) Antibody Sales by Country (2019-2030)
3.7.3 Latin America CD25 (IL2R alpha) Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD25 (IL2R alpha) Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CD25 (IL2R alpha) Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa CD25 (IL2R alpha) Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa CD25 (IL2R alpha) Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD25 (IL2R alpha) Antibody Sales by Type (2019-2030)
4.1.1 Global CD25 (IL2R alpha) Antibody Sales by Type (2019-2024)
4.1.2 Global CD25 (IL2R alpha) Antibody Sales by Type (2025-2030)
4.1.3 Global CD25 (IL2R alpha) Antibody Sales Market Share by Type (2019-2030)
4.2 Global CD25 (IL2R alpha) Antibody Revenue by Type (2019-2030)
4.2.1 Global CD25 (IL2R alpha) Antibody Revenue by Type (2019-2024)
4.2.2 Global CD25 (IL2R alpha) Antibody Revenue by Type (2025-2030)
4.2.3 Global CD25 (IL2R alpha) Antibody Revenue Market Share by Type (2019-2030)
4.3 Global CD25 (IL2R alpha) Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global CD25 (IL2R alpha) Antibody Sales by Application (2019-2030)
5.1.1 Global CD25 (IL2R alpha) Antibody Sales by Application (2019-2024)
5.1.2 Global CD25 (IL2R alpha) Antibody Sales by Application (2025-2030)
5.1.3 Global CD25 (IL2R alpha) Antibody Sales Market Share by Application (2019-2030)
5.2 Global CD25 (IL2R alpha) Antibody Revenue by Application (2019-2030)
5.2.1 Global CD25 (IL2R alpha) Antibody Revenue by Application (2019-2024)
5.2.2 Global CD25 (IL2R alpha) Antibody Revenue by Application (2025-2030)
5.2.3 Global CD25 (IL2R alpha) Antibody Revenue Market Share by Application (2019-2030)
5.3 Global CD25 (IL2R alpha) Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sino Biological, Inc.
6.1.1 Sino Biological, Inc. Corporation Information
6.1.2 Sino Biological, Inc. Description and Business Overview
6.1.3 Sino Biological, Inc. CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sino Biological, Inc. CD25 (IL2R alpha) Antibody Product Portfolio
6.1.5 Sino Biological, Inc. Recent Developments/Updates
6.2 LifeSpan BioSciences, Inc
6.2.1 LifeSpan BioSciences, Inc Corporation Information
6.2.2 LifeSpan BioSciences, Inc Description and Business Overview
6.2.3 LifeSpan BioSciences, Inc CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LifeSpan BioSciences, Inc CD25 (IL2R alpha) Antibody Product Portfolio
6.2.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.3 Bio-Techne
6.3.1 Bio-Techne Corporation Information
6.3.2 Bio-Techne Description and Business Overview
6.3.3 Bio-Techne CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bio-Techne CD25 (IL2R alpha) Antibody Product Portfolio
6.3.5 Bio-Techne Recent Developments/Updates
6.4 Abeomics Inc.
6.4.1 Abeomics Inc. Corporation Information
6.4.2 Abeomics Inc. Description and Business Overview
6.4.3 Abeomics Inc. CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abeomics Inc. CD25 (IL2R alpha) Antibody Product Portfolio
6.4.5 Abeomics Inc. Recent Developments/Updates
6.5 Abcam
6.5.1 Abcam Corporation Information
6.5.2 Abcam Description and Business Overview
6.5.3 Abcam CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abcam CD25 (IL2R alpha) Antibody Product Portfolio
6.5.5 Abcam Recent Developments/Updates
6.6 Boster Biological Technology
6.6.1 Boster Biological Technology Corporation Information
6.6.2 Boster Biological Technology Description and Business Overview
6.6.3 Boster Biological Technology CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boster Biological Technology CD25 (IL2R alpha) Antibody Product Portfolio
6.6.5 Boster Biological Technology Recent Developments/Updates
6.7 MyBiosource, Inc.
6.6.1 MyBiosource, Inc. Corporation Information
6.6.2 MyBiosource, Inc. Description and Business Overview
6.6.3 MyBiosource, Inc. CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MyBiosource, Inc. CD25 (IL2R alpha) Antibody Product Portfolio
6.7.5 MyBiosource, Inc. Recent Developments/Updates
6.8 BioLegend
6.8.1 BioLegend Corporation Information
6.8.2 BioLegend Description and Business Overview
6.8.3 BioLegend CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BioLegend CD25 (IL2R alpha) Antibody Product Portfolio
6.8.5 BioLegend Recent Developments/Updates
6.9 Abbexa
6.9.1 Abbexa Corporation Information
6.9.2 Abbexa Description and Business Overview
6.9.3 Abbexa CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Abbexa CD25 (IL2R alpha) Antibody Product Portfolio
6.9.5 Abbexa Recent Developments/Updates
6.10 Merck
6.10.1 Merck Corporation Information
6.10.2 Merck Description and Business Overview
6.10.3 Merck CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Merck CD25 (IL2R alpha) Antibody Product Portfolio
6.10.5 Merck Recent Developments/Updates
6.11 Arigo Biolaboratories Corp.
6.11.1 Arigo Biolaboratories Corp. Corporation Information
6.11.2 Arigo Biolaboratories Corp. CD25 (IL2R alpha) Antibody Description and Business Overview
6.11.3 Arigo Biolaboratories Corp. CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Arigo Biolaboratories Corp. CD25 (IL2R alpha) Antibody Product Portfolio
6.11.5 Arigo Biolaboratories Corp. Recent Developments/Updates
6.12 Leinco Technologies
6.12.1 Leinco Technologies Corporation Information
6.12.2 Leinco Technologies CD25 (IL2R alpha) Antibody Description and Business Overview
6.12.3 Leinco Technologies CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Leinco Technologies CD25 (IL2R alpha) Antibody Product Portfolio
6.12.5 Leinco Technologies Recent Developments/Updates
6.13 Diagnostic BioSystems
6.13.1 Diagnostic BioSystems Corporation Information
6.13.2 Diagnostic BioSystems CD25 (IL2R alpha) Antibody Description and Business Overview
6.13.3 Diagnostic BioSystems CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Diagnostic BioSystems CD25 (IL2R alpha) Antibody Product Portfolio
6.13.5 Diagnostic BioSystems Recent Developments/Updates
6.14 Creative Diagnostics
6.14.1 Creative Diagnostics Corporation Information
6.14.2 Creative Diagnostics CD25 (IL2R alpha) Antibody Description and Business Overview
6.14.3 Creative Diagnostics CD25 (IL2R alpha) Antibody Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Creative Diagnostics CD25 (IL2R alpha) Antibody Product Portfolio
6.14.5 Creative Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD25 (IL2R alpha) Antibody Industry Chain Analysis
7.2 CD25 (IL2R alpha) Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD25 (IL2R alpha) Antibody Production Mode & Process
7.4 CD25 (IL2R alpha) Antibody Sales and Marketing
7.4.1 CD25 (IL2R alpha) Antibody Sales Channels
7.4.2 CD25 (IL2R alpha) Antibody Distributors
7.5 CD25 (IL2R alpha) Antibody Customers
8 CD25 (IL2R alpha) Antibody Market Dynamics
8.1 CD25 (IL2R alpha) Antibody Industry Trends
8.2 CD25 (IL2R alpha) Antibody Market Drivers
8.3 CD25 (IL2R alpha) Antibody Market Challenges
8.4 CD25 (IL2R alpha) Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Lifespan Biosciences Inc.
Bio-Techne
Abeomics
Abcam
Boster Biological Technology
MyBioSource
Abbexa
Merck
Arigo Biolaboratories Corp
Leinco Technologies
Diagnostic BioSystems
Creative Diagnostics
BioLegend
Sino Biological Inc
List of Tables
    Table 1. Global CD25 (IL2R alpha) Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global CD25 (IL2R alpha) Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global CD25 (IL2R alpha) Antibody Market Competitive Situation by Manufacturers in 2023
    Table 4. Global CD25 (IL2R alpha) Antibody Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global CD25 (IL2R alpha) Antibody Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global CD25 (IL2R alpha) Antibody Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global CD25 (IL2R alpha) Antibody Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market CD25 (IL2R alpha) Antibody Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of CD25 (IL2R alpha) Antibody, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of CD25 (IL2R alpha) Antibody, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of CD25 (IL2R alpha) Antibody, Product Type & Application
    Table 12. Global Key Manufacturers of CD25 (IL2R alpha) Antibody, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global CD25 (IL2R alpha) Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD25 (IL2R alpha) Antibody as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global CD25 (IL2R alpha) Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global CD25 (IL2R alpha) Antibody Sales by Region (2019-2024) & (K Units)
    Table 18. Global CD25 (IL2R alpha) Antibody Sales Market Share by Region (2019-2024)
    Table 19. Global CD25 (IL2R alpha) Antibody Sales by Region (2025-2030) & (K Units)
    Table 20. Global CD25 (IL2R alpha) Antibody Sales Market Share by Region (2025-2030)
    Table 21. Global CD25 (IL2R alpha) Antibody Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global CD25 (IL2R alpha) Antibody Revenue Market Share by Region (2019-2024)
    Table 23. Global CD25 (IL2R alpha) Antibody Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global CD25 (IL2R alpha) Antibody Revenue Market Share by Region (2025-2030)
    Table 25. North America CD25 (IL2R alpha) Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America CD25 (IL2R alpha) Antibody Sales by Country (2019-2024) & (K Units)
    Table 27. North America CD25 (IL2R alpha) Antibody Sales by Country (2025-2030) & (K Units)
    Table 28. North America CD25 (IL2R alpha) Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America CD25 (IL2R alpha) Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe CD25 (IL2R alpha) Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe CD25 (IL2R alpha) Antibody Sales by Country (2019-2024) & (K Units)
    Table 32. Europe CD25 (IL2R alpha) Antibody Sales by Country (2025-2030) & (K Units)
    Table 33. Europe CD25 (IL2R alpha) Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe CD25 (IL2R alpha) Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific CD25 (IL2R alpha) Antibody Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific CD25 (IL2R alpha) Antibody Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific CD25 (IL2R alpha) Antibody Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific CD25 (IL2R alpha) Antibody Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific CD25 (IL2R alpha) Antibody Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America CD25 (IL2R alpha) Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America CD25 (IL2R alpha) Antibody Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America CD25 (IL2R alpha) Antibody Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America CD25 (IL2R alpha) Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America CD25 (IL2R alpha) Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa CD25 (IL2R alpha) Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa CD25 (IL2R alpha) Antibody Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa CD25 (IL2R alpha) Antibody Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa CD25 (IL2R alpha) Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa CD25 (IL2R alpha) Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global CD25 (IL2R alpha) Antibody Sales (K Units) by Type (2019-2024)
    Table 51. Global CD25 (IL2R alpha) Antibody Sales (K Units) by Type (2025-2030)
    Table 52. Global CD25 (IL2R alpha) Antibody Sales Market Share by Type (2019-2024)
    Table 53. Global CD25 (IL2R alpha) Antibody Sales Market Share by Type (2025-2030)
    Table 54. Global CD25 (IL2R alpha) Antibody Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global CD25 (IL2R alpha) Antibody Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global CD25 (IL2R alpha) Antibody Revenue Market Share by Type (2019-2024)
    Table 57. Global CD25 (IL2R alpha) Antibody Revenue Market Share by Type (2025-2030)
    Table 58. Global CD25 (IL2R alpha) Antibody Price (US$/Unit) by Type (2019-2024)
    Table 59. Global CD25 (IL2R alpha) Antibody Price (US$/Unit) by Type (2025-2030)
    Table 60. Global CD25 (IL2R alpha) Antibody Sales (K Units) by Application (2019-2024)
    Table 61. Global CD25 (IL2R alpha) Antibody Sales (K Units) by Application (2025-2030)
    Table 62. Global CD25 (IL2R alpha) Antibody Sales Market Share by Application (2019-2024)
    Table 63. Global CD25 (IL2R alpha) Antibody Sales Market Share by Application (2025-2030)
    Table 64. Global CD25 (IL2R alpha) Antibody Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global CD25 (IL2R alpha) Antibody Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global CD25 (IL2R alpha) Antibody Revenue Market Share by Application (2019-2024)
    Table 67. Global CD25 (IL2R alpha) Antibody Revenue Market Share by Application (2025-2030)
    Table 68. Global CD25 (IL2R alpha) Antibody Price (US$/Unit) by Application (2019-2024)
    Table 69. Global CD25 (IL2R alpha) Antibody Price (US$/Unit) by Application (2025-2030)
    Table 70. Sino Biological, Inc. Corporation Information
    Table 71. Sino Biological, Inc. Description and Business Overview
    Table 72. Sino Biological, Inc. CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Sino Biological, Inc. CD25 (IL2R alpha) Antibody Product
    Table 74. Sino Biological, Inc. Recent Developments/Updates
    Table 75. LifeSpan BioSciences, Inc Corporation Information
    Table 76. LifeSpan BioSciences, Inc Description and Business Overview
    Table 77. LifeSpan BioSciences, Inc CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. LifeSpan BioSciences, Inc CD25 (IL2R alpha) Antibody Product
    Table 79. LifeSpan BioSciences, Inc Recent Developments/Updates
    Table 80. Bio-Techne Corporation Information
    Table 81. Bio-Techne Description and Business Overview
    Table 82. Bio-Techne CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Bio-Techne CD25 (IL2R alpha) Antibody Product
    Table 84. Bio-Techne Recent Developments/Updates
    Table 85. Abeomics Inc. Corporation Information
    Table 86. Abeomics Inc. Description and Business Overview
    Table 87. Abeomics Inc. CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Abeomics Inc. CD25 (IL2R alpha) Antibody Product
    Table 89. Abeomics Inc. Recent Developments/Updates
    Table 90. Abcam Corporation Information
    Table 91. Abcam Description and Business Overview
    Table 92. Abcam CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Abcam CD25 (IL2R alpha) Antibody Product
    Table 94. Abcam Recent Developments/Updates
    Table 95. Boster Biological Technology Corporation Information
    Table 96. Boster Biological Technology Description and Business Overview
    Table 97. Boster Biological Technology CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Boster Biological Technology CD25 (IL2R alpha) Antibody Product
    Table 99. Boster Biological Technology Recent Developments/Updates
    Table 100. MyBiosource, Inc. Corporation Information
    Table 101. MyBiosource, Inc. Description and Business Overview
    Table 102. MyBiosource, Inc. CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. MyBiosource, Inc. CD25 (IL2R alpha) Antibody Product
    Table 104. MyBiosource, Inc. Recent Developments/Updates
    Table 105. BioLegend Corporation Information
    Table 106. BioLegend Description and Business Overview
    Table 107. BioLegend CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. BioLegend CD25 (IL2R alpha) Antibody Product
    Table 109. BioLegend Recent Developments/Updates
    Table 110. Abbexa Corporation Information
    Table 111. Abbexa Description and Business Overview
    Table 112. Abbexa CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Abbexa CD25 (IL2R alpha) Antibody Product
    Table 114. Abbexa Recent Developments/Updates
    Table 115. Merck Corporation Information
    Table 116. Merck Description and Business Overview
    Table 117. Merck CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Merck CD25 (IL2R alpha) Antibody Product
    Table 119. Merck Recent Developments/Updates
    Table 120. Arigo Biolaboratories Corp. Corporation Information
    Table 121. Arigo Biolaboratories Corp. Description and Business Overview
    Table 122. Arigo Biolaboratories Corp. CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Arigo Biolaboratories Corp. CD25 (IL2R alpha) Antibody Product
    Table 124. Arigo Biolaboratories Corp. Recent Developments/Updates
    Table 125. Leinco Technologies Corporation Information
    Table 126. Leinco Technologies Description and Business Overview
    Table 127. Leinco Technologies CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Leinco Technologies CD25 (IL2R alpha) Antibody Product
    Table 129. Leinco Technologies Recent Developments/Updates
    Table 130. Diagnostic BioSystems Corporation Information
    Table 131. Diagnostic BioSystems Description and Business Overview
    Table 132. Diagnostic BioSystems CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Diagnostic BioSystems CD25 (IL2R alpha) Antibody Product
    Table 134. Diagnostic BioSystems Recent Developments/Updates
    Table 135. Creative Diagnostics Corporation Information
    Table 136. Creative Diagnostics Description and Business Overview
    Table 137. Creative Diagnostics CD25 (IL2R alpha) Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Creative Diagnostics CD25 (IL2R alpha) Antibody Product
    Table 139. Creative Diagnostics Recent Developments/Updates
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. CD25 (IL2R alpha) Antibody Distributors List
    Table 143. CD25 (IL2R alpha) Antibody Customers List
    Table 144. CD25 (IL2R alpha) Antibody Market Trends
    Table 145. CD25 (IL2R alpha) Antibody Market Drivers
    Table 146. CD25 (IL2R alpha) Antibody Market Challenges
    Table 147. CD25 (IL2R alpha) Antibody Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of CD25 (IL2R alpha) Antibody
    Figure 2. Global CD25 (IL2R alpha) Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global CD25 (IL2R alpha) Antibody Market Share by Type in 2023 & 2030
    Figure 4. Monoclonal Antibody Product Picture
    Figure 5. Polyclonal Antibody Product Picture
    Figure 6. Global CD25 (IL2R alpha) Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global CD25 (IL2R alpha) Antibody Market Share by Application in 2023 & 2030
    Figure 8. Flow Cytometry
    Figure 9. ELISA
    Figure 10. Western Blot
    Figure 11. Immunoprecipitation
    Figure 12. Immunofluorescence
    Figure 13. Others
    Figure 14. Global CD25 (IL2R alpha) Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global CD25 (IL2R alpha) Antibody Market Size (2019-2030) & (US$ Million)
    Figure 16. Global CD25 (IL2R alpha) Antibody Sales (2019-2030) & (K Units)
    Figure 17. Global CD25 (IL2R alpha) Antibody Average Price (US$/Unit) & (2019-2030)
    Figure 18. CD25 (IL2R alpha) Antibody Report Years Considered
    Figure 19. CD25 (IL2R alpha) Antibody Sales Share by Manufacturers in 2023
    Figure 20. Global CD25 (IL2R alpha) Antibody Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest CD25 (IL2R alpha) Antibody Players: Market Share by Revenue in 2023
    Figure 22. CD25 (IL2R alpha) Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global CD25 (IL2R alpha) Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America CD25 (IL2R alpha) Antibody Sales Market Share by Country (2019-2030)
    Figure 25. North America CD25 (IL2R alpha) Antibody Revenue Market Share by Country (2019-2030)
    Figure 26. United States CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe CD25 (IL2R alpha) Antibody Sales Market Share by Country (2019-2030)
    Figure 29. Europe CD25 (IL2R alpha) Antibody Revenue Market Share by Country (2019-2030)
    Figure 30. Germany CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific CD25 (IL2R alpha) Antibody Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific CD25 (IL2R alpha) Antibody Revenue Market Share by Region (2019-2030)
    Figure 37. China CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. China Taiwan CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America CD25 (IL2R alpha) Antibody Sales Market Share by Country (2019-2030)
    Figure 45. Latin America CD25 (IL2R alpha) Antibody Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa CD25 (IL2R alpha) Antibody Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa CD25 (IL2R alpha) Antibody Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE CD25 (IL2R alpha) Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of CD25 (IL2R alpha) Antibody by Type (2019-2030)
    Figure 55. Global Revenue Market Share of CD25 (IL2R alpha) Antibody by Type (2019-2030)
    Figure 56. Global CD25 (IL2R alpha) Antibody Price (US$/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of CD25 (IL2R alpha) Antibody by Application (2019-2030)
    Figure 58. Global Revenue Market Share of CD25 (IL2R alpha) Antibody by Application (2019-2030)
    Figure 59. Global CD25 (IL2R alpha) Antibody Price (US$/Unit) by Application (2019-2030)
    Figure 60. CD25 (IL2R alpha) Antibody Value Chain
    Figure 61. CD25 (IL2R alpha) Antibody Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global CD25 IL2R alpha Protein Market Research Report 2024
Global CD25 IL2R alpha ELISA Kit Market Research Report 2024
Global Anti CD25 Monoclonal Antibody Market Research Report 2024
Global Anti CD20 Monoclonal Antibodies Market Research Report 2024
CD320 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CD40 Ligand CD40L Antibody Market Research Report 2024
IL 4 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
E2 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
CD11b Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Interleukin 2 Receptor Subunit Alpha Market Research Report 2025
Global Bcl 2 Antibody Market Research Report 2024
Global Granulocytes Antibody Market Research Report 2024
Global Bovine Interleukin 2 IL2 ELISA Kit Market Research Report 2024
Global HER2 Human Epidermal Growth Factor Receptor 2 Antibody Market Research Report 2024
Global F11R Antibody Market Research Report 2024
Global Research Area Antibodies Market Research Report 2025
Global CD244 2B4 Protein Market Research Report 2024
Global Erythrocytes Antibody Market Research Report 2024
Global IL 4Rα Monoclonal Antibody Drug Market Research Report 2024
Global Erythrocytes Monoclonal Antibody Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions